Skip to Main Content

Author Details

Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
2010
32
9
PMIDPaper TitleJournal TitlePublished Year
36397716Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer.Cancer Med2023
37622340Patient-specific simulations and navigation systems for partial nephrectomy.Int J Urol2023
37182269Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.EBioMedicine2023
36403677Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates.Urology2023
34698452Training on a virtual reality laparoscopic simulator improves performance of live laparoscopic surgery.Asian J Endosc Surg2022
35426565Objective assessment of laparoscopic targeting skills using a Short-Time Power of Difference (STPOD) method.Int J Comput Assist Radiol Surg2022
35874919Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers.iScience2022
36128328Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.Oncotarget2022
33140511Clinical use of a patient-specific simulator for patients who were scheduled for robot-assisted laparoscopic partial nephrectomy.Int J Urol2021
34126664[A Case of Lymphoepithelioma-Like Carcinoma of the Ureter].Hinyokika Kiyo2021
33258261How to reduce the risk of organ injuries during surgical instrument insertion in laparoscopic surgery: Pushing/pressing force analysis using forceps with sensors.Asian J Endosc Surg2021
32253774Validation of a kidney model made of N-composite gel as a training tool for laparoscopic partial nephrectomy.Int J Urol2020
31895931A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.PLoS One2020
32537714C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.Cancer Chemother Pharmacol2020
30326476Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naïve Prostate Cancer.Urol Int2019
29681816Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report.Case Rep Oncol2018
30112175Oxidative stress marker 8-hydroxyguanosine is more highly expressed in prostate cancer than in benign prostatic hyperplasia.Mol Clin Oncol2018
29977636Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial Nephrectomy.Case Rep Oncol Med2018
30400941PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.BMC Urol2018
29669553Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report.BMC Urol2018
28641939Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancer.Urol Oncol2017
28497065A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.Biomed Res Int2017
28785198Fracture Risk in Prostate Cancer during Hormonal Therapy.Curr Urol2017
26944862Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.BMC Cancer2016
27822480Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.Biomed Res Int2016
27447553ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.Oncotarget2016
26497861[A Case of Abdominal Wall Desmoid Tumor after Radical Nephrectomy for Renal Cancer].Hinyokika Kiyo2015
24755817[A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].Hinyokika Kiyo2014
23635463[Four cases of penile fracture].Hinyokika Kiyo2013
24455395Laparoscopic nephroureterectomy for adult patient with primary obstructive megaureter.Case Rep Urol2013
23945329[Vesical tuberculosis after Bacillus Calmette-Guerin intravesical instillation therapy for bladder cancer].Hinyokika Kiyo2013
20825631Duodenal gastrointestinal stromal tumor resembling a pancreatic neuroendocrine tumor in a patient with neurofibromatosis type I (von Recklinghausen's disease): a case report.J Med Case Rep2010
  • 1 - 32 of 32

Recommended Authors

Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 4
Careggi University Hospital
Career Start Year 2014
Number of shared co-authors 1
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 1
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 4
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 5
University of Florida
Career Start Year 2005
Number of shared co-authors 1
University of California San Diego
Career Start Year 2005
Number of shared co-authors 3
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
university of california san diego School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
university of california san diego School of Medicine
Career Start Year 1998
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 2
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 3
University of Melbourne
Career Start Year 1988
Number of shared co-authors 1
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 2
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 3

Collaborators

University of California los angeles
Co-authored papers 5
Co-authored papers 2
RIKEN Center for Integrative Medical Sciences
Co-authored papers 2
Institute of Urologic Oncology, University of California Los Angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Stomatology Hospital, Zhejiang University School of Medicine
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Veracyte inc.
Co-authored papers 1
institute of urology
Co-authored papers 1
Co-authored papers 1
Yale University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Veracyte Inc.
Co-authored papers 1
Yale University
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Karmanos Cancer Institute, Wayne State University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Human Genome Center, The Institute of Medical Science, The University of Tokyo
Co-authored papers 1
College of Optical Science and Engineering, Zhejiang University
Co-authored papers 1
Advanced Medical Research Center, Yokohama City University
Co-authored papers 1
Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
David Geffen School of Medicine , University of California los angeles
Co-authored papers 1